Microcirculation dynamics in systemic vasculitis: evidence of impaired microvascular response regardless of cardiovascular risk factors

Rheumatology - Tập 62 Số 7 - Trang 2510-2516 - 2023
Panagiotis Dolgyras1, Αntonios Lazaridis1, Panagiota Anyfanti1, Eleni Gavriilaki1, Nikolaos Koletsos1, Αreti Triantafyllou1, Barbara Nikolaidou1, Vasiliki Galanapoulou2, Στέλλα Δούμα1, Εugenia Gkaliagkousi1
13rd Department of Internal Medicine, Papageorgiou Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece
2Department of Rheumatology, Papageorgiou Hospital , Thessaloniki, Greece

Tóm tắt

Abstract Objectives Systemic vasculitides (SVs) are a highly inflammatory group of diseases characterized by significant cardiovascular (CV) mortality. Microvascular damage closely linked with accelerated atherosclerosis and thrombosis represents a core pathophysiological mechanism contributing to the excess CV risk of patients with SVs. Skin represents an easily accessible tissue facilitating non-invasive microvascular study. In this study we aimed to investigate microcirculation dynamics and associate them with disease-related factors in patients with SVs. Methods We assessed skin microcirculation using laser speckle contrast imaging (LSCI) and vascular reactivity by the post-occlusive reactive hyperaemia (PORH) protocol in a meticulously selected group of patients with SVs without CV disease and compared them to controls, matched for age, sex, BMI and smoking status. Results Sixty individuals were included in the study, 30 patients and 30 controls. Patients with SVs presented a lower peak magnitude during reperfusion phase (median [interquartile range] 207 [60.1] vs 143.7 [41.0] laser speckle perfusion units, P < 0.001) and lower percentage cutaneous vascular conductance increase (mean (s.d.) 190.0 [49.6]% vs 149.6 [48.9]%, P = 0.002) as compared with controls. Importantly, microvascular damage was correlated with disease duration (P < 0.001, r = −0.563 and P < 0.001, r = 0.442, respectively). Conclusion For the first time we have shown that patients with SVs exhibit impaired microvascular function and blunted reactivity after occlusion, as this was demonstrated by the LSCI technique. Therefore, skin microcirculation may be a useful, non-invasive method in patients with SVs for the early detection of microvascular dysfunction, which is closely related to the high CV risk that these patients bear.

Từ khóa


Tài liệu tham khảo

Holle, 2011, Improved outcome in 445 patients with Wegener’s granulomatosis in a German vasculitis center over four decades, Arthritis Rheum, 63, 257, 10.1002/art.27763

Von Feldt, 2008, Premature atherosclerotic cardiovascular disease and systemic lupus erythematosus: from bedside to bench, Bull NYU Hosp Joint Dis, 66, 184

Meune, 2009, Trends in cardiovascular mortality in patients with rheumatoid arthritis over 50 years: a systematic review and meta-analysis of cohort studies, Rheumatology (Oxford), 48, 1309, 10.1093/rheumatology/kep252

Flossmann, 2011, Long-term patient survival in ANCA-associated vasculitis, Ann Rheum Dis, 70, 488, 10.1136/ard.2010.137778

Suppiah, 2011, A model to predict cardiovascular events in patients with newly diagnosed Wegener’s granulomatosis and microscopic polyangiitis, Arthritis Care Res (Hoboken), 63, 588, 10.1002/acr.20433

Ahn, 2020, Increased cardiovascular risk and all-cause death in patients with Behçet disease: a Korean nationwide population-based dynamic cohort study, J Rheumatol, 47, 903, 10.3899/jrheum.190408

Jardel, 2018, Mortality in systemic necrotizing vasculitides: a retrospective analysis of the French Vasculitis Study Group registry, Autoimmun Rev, 17, 653, 10.1016/j.autrev.2018.01.022

Thomas, 2020, Epidemiology, morbidity and mortality in Behçet’s disease: a cohort study using The Health Improvement Network (THIN), Rheumatology (Oxford), 59, 2785, 10.1093/rheumatology/keaa010

Robson, 2015, Damage in the anca-associated vasculitides: long-term data from the European vasculitis study group (EUVAS) therapeutic trials, Ann Rheum Dis, 74, 177, 10.1136/annrheumdis-2013-203927

Agabiti-Rosei, 2017, Microvascular structure as a prognostically relevant endpoint, J Hypertension, 35, 914, 10.1097/HJH.0000000000001259

Gkaliagkousi, 2015, Clinical significance of endothelial dysfunction in essential hypertension, Curr Hypertension Rep, 17, 85, 10.1007/s11906-015-0596-3

Levy, 2008, Impaired tissue perfusion: a pathology common to hypertension, obesity, and diabetes mellitus, Circulation, 118, 968, 10.1161/CIRCULATIONAHA.107.763730

Yildiz, 2008, Commentary on Viewpoint: The human cutaneous circulation as a model of generalized microvascular function, J Appl Physiol, 105, 382, 10.1152/japplphysiol.90316.2006

Mahé, 2012, Assessment of skin microvascular function and dysfunction with laser speckle contrast imaging, Circ Cardiovasc Imaging, 5, 155, 10.1161/CIRCIMAGING.111.970418

Roustit, 2013, Assessment of endothelial and neurovascular function in human skin microcirculation, Trends Pharmacol Sci, 34, 373, 10.1016/j.tips.2013.05.007

Roustit, 2010, Excellent reproducibility of laser speckle contrast imaging to assess skin microvascular reactivity, Microvasc Res, 80, 505, 10.1016/j.mvr.2010.05.012

Humeau-Heurtier, 2014, Excellent inter- and intra-observer reproducibility of microvascular tests using laser speckle contrast imaging, Clin Hemorheol Microcirc, 58, 439, 10.3233/CH-131804

Ruaro, 2014, Laser speckle contrast analysis: a new method to evaluate peripheral blood perfusion in systemic sclerosis patients, Ann Rheum Dis, 73, 1181, 10.1136/annrheumdis-2013-203514

Koletsos, 2021, Skin microvascular dysfunction in systemic lupus erythematosus patients with and without cardiovascular risk factors, Rheumatology, 60, 2834, 10.1093/rheumatology/keaa722

Filer, 2003, Diffuse endothelial dysfunction is common to ANCA associated systemic vasculitis and polyarteritis nodosa, Ann Rheum Dis, 62, 162, 10.1136/ard.62.2.162

Huang, 2012, Deterioration of cutaneous microcirculatory status of Kawasaki disease, Clin Rheumatol, 31, 847, 10.1007/s10067-012-1948-x

World Medical Association Declaration of Helsinki, 2013, JAMA, 310, 2191, 10.1001/jama.2013.281053

Mukhtyar, 2009, Modification and validation of the Birmingham vasculitis activity score (version 3), Ann Rheum Dis, 68, 1827, 10.1136/ard.2008.101279

Williams, 2018, 2018 ESC/ESH Guidelines for the management of arterial hypertension, Eur Heart J, 39, 3021, 10.1093/eurheartj/ehy339

Boas, 2010, Laser speckle contrast imaging in biomedical optics, J Biomed Opt, 15, 011109, 10.1117/1.3285504

Draijer, 2009, Review of laser speckle contrast techniques for visualizing tissue perfusion, Lasers Med Sci, 24, 639, 10.1007/s10103-008-0626-3

Briers, 1999, Capillary blood flow monitoring using Laser Speckle Contrast Analysis (LASCA), J Biomed Opt, 4, 164, 10.1117/1.429903

Heeman, 2019, Clinical applications of laser speckle contrast imaging: a review, J Biomed Opt, 24, 1, 10.1117/1.JBO.24.8.080901

Senarathna, 2013, Laser speckle contrast imaging: theory, instrumentation and applications, IEEE Rev Biomed Eng, 6, 99, 10.1109/RBME.2013.2243140

Briers, 2001, Laser Doppler, speckle and related techniques for blood perfusion mapping and imaging, Physiological Measurement, 22, R35, 10.1088/0967-3334/22/4/201

Mahé, 2011, Distance between laser head and skin does not influence skin blood flow values recorded by laser speckle imaging, Microvasc Res, 82, 439, 10.1016/j.mvr.2011.06.014

Tee, 2004, Dependence of human forearm skin postocclusive reactive hyperemia on occlusion time, J Pharmacol Toxicol Methods, 50, 73, 10.1016/j.vascn.2004.02.002

Rousseau, 2011, Increasing the “region of interest” and “time of interest”, both reduce the variability of blood flow measurements using laser speckle contrast imaging, Microvasc Res, 82, 88, 10.1016/j.mvr.2011.03.009

Aytekin, 2014, Nailfold capillaroscopy in Behçet disease, performed using videodermoscopy, Clin Exp Dermatol, 39, 443, 10.1111/ced.12343

Nienhuis, 2007, Enhanced endothelium-dependent microvascular responses in patients with Wegener’s granulomatosis, J Rheumatol, 34, 1875

Della Rossa, 2013, Alteration of microcirculation is a hallmark of very early systemic sclerosis patients: a laser speckle contrast analysis, Clin Exp Rheumatol, 31, 109

Pacholczak, 2019, Endothelial dysfunction in patients with eosinophilic granulomatosis with polyangiitis, Clin Rheumatol, 38, 417, 10.1007/s10067-018-4253-5

Ozuguz, 2014, Markers of endothelial dysfunction and evaluation of vascular reactivity tests in Behçet disease, Angiology, 65, 937, 10.1177/0003319713512413

Souza, 2014, Impairment of systemic microvascular endothelial and smooth muscle function in individuals with early-onset coronary artery disease: studies with laser speckle contrast imaging, Coron Artery Dis, 25, 23, 10.1097/MCA.0000000000000055

Cordovil, 2012, Evaluation of systemic microvascular endothelial function using laser speckle contrast imaging, Microvasc Res, 83, 376, 10.1016/j.mvr.2012.01.004

Lazaridis, 2021, Masked hypertensives as assessed with laser speckle contrast imaging exhibit impaired skin microvascular reactivity similar to essential hypertensive individuals, J Hypertens, 39, e326, 10.1097/01.hjh.0000748276.72234.fe

Gavriilaki, 2022, A non-interventional study of microcirculation dynamics in allogeneic hematopoietic cell transplantation survivors compared to controls: evidence of impaired microvascular response regardless of conventional cardiovascular risk factors, Bone Marrow Transplant, 57, 72, 10.1038/s41409-021-01500-w

Millet, 2011, Comparison between laser speckle contrast imaging and laser Doppler imaging to assess skin blood flow in humans, Microvasc Res, 82, 147, 10.1016/j.mvr.2011.06.006

Tew, 2011, Comparison of laser speckle contrast imaging with laser Doppler for assessing microvascular function, Microvasc Res, 82, 326, 10.1016/j.mvr.2011.07.007

Mohammad, 2020, An update on the epidemiology of ANCA-associated vasculitis, Rheumatology (Oxford), 59, iii42, 10.1093/rheumatology/keaa089

Andrianakos, 2003, Prevalence of rheumatic diseases in Greece: a cross-sectional population based epidemiological study. The ESORDIG Study, J Rheumatol, 30, 1589